Aganirsen
- Generic Name
- Aganirsen
- Drug Type
- Biotech
- CAS Number
- 1146887-67-3
- Unique Ingredient Identifier
- 0N3FY8225K
- Background
Aganirsen is under investigation in clinical trial NCT02947867 (Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG).
Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
Phase 2
- Conditions
- Ischaemic Central Retinal Vein OcclusionNeovascular Glaucoma
- Interventions
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2016-10-31
- Lead Sponsor
- Gene Signal SAS
- Target Recruit Count
- 333
- Registration Number
- NCT02947867
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath